Lukas Scheibler
Chief Tech/Sci/R&D Officer at APELLIS PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 2024-04-29
Profile
Lukas Scheibler is currently the Chief Research Officer at Apellis Pharmaceuticals, Inc. He previously worked as the Head-Clinical Development at Novartis Corp.
from 2002 to 2008.
From 2011 to 2015, he served as the Vice President at Alcon Laboratories, Inc. Additionally, he held the position of Executive Vice President-Translational Medicine at Acucela, Inc. from 2015 to 2017.
Dr. Scheibler obtained a graduate degree from the University of Basel and a doctorate degree from the University of Lausanne.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-11-30 | 68,299 ( 0.06% ) | 3 M $ | 2024-04-29 |
Lukas Scheibler active positions
| Companies | Position | Start |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Lukas Scheibler
| Companies | Position | End |
|---|---|---|
| ACUCELA INC | Corporate Officer/Principal | 2017-11-30 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 2015-06-30 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 2008-05-31 |
Training of Lukas Scheibler
| University of Basel | Graduate Degree |
| University of Lausanne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Lukas Scheibler